Steven N. Chatfield

2012

In 2012, Steven N. Chatfield earned a total compensation of $842.3K as Executive Vice President, Strategic Investments Division (formerly Executive Vice President, Biosciences Division at Emergent BioSolutions, a 19% increase compared to previous year.

Compensation breakdown

Bonus$139,404
Option Awards$139,866
Salary$344,208
Stock Awards$174,051
Other$44,747
Total$842,276

Chatfield received $344.2K in salary, accounting for 41% of the total pay in 2012.

Chatfield also received $139.4K in bonus, $139.9K in option awards, $174.1K in stock awards and $44.7K in other compensation.

Rankings

In 2012, Steven N. Chatfield's compensation ranked 6,809th out of 11,487 executives tracked by ExecPay. In other words, Chatfield earned more than 40.7% of executives.

ClassificationRankingPercentile
All
6,809
out of 11,487
41st
Division
Manufacturing
2,440
out of 4,253
43rd
Major group
Chemicals And Allied Products
618
out of 1,198
48th
Industry group
Drugs
423
out of 920
54th
Industry
Pharmaceutical Preparations
331
out of 700
53rd
Source: SEC filing on April 7, 2014.

Chatfield's colleagues

We found five more compensation records of executives who worked with Steven N. Chatfield at Emergent BioSolutions in 2012.

2012

Daniel Abdun-Nabi

Emergent BioSolutions

Chief Executive Officer

2012

Fuad El-Hibri

Emergent BioSolutions

Chairman

2012

Robert Kramer

Emergent BioSolutions

Chief Financial Officer

2012

Adam Havey

Emergent BioSolutions

Executive Vice President, Biodefense Division

2012

R Elsey

Emergent BioSolutions

Chief Financial Officer

You may also like